115 related articles for article (PubMed ID: 20148711)
1. Investigation of self-microemulsifying and microemulsion systems for protection of prednisolone from gamma radiation.
El Maghraby GM; Bosela AA
Pharm Dev Technol; 2011 Jun; 16(3):237-42. PubMed ID: 20148711
[TBL] [Abstract][Full Text] [Related]
2. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition.
El Maghraby GM
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):595-600. PubMed ID: 19892531
[TBL] [Abstract][Full Text] [Related]
3. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
4. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery.
Ren X; Svirskis D; Alany RG; Zargar-Shoshtari S; Wu Z
Int J Pharm; 2012 Jul; 431(1-2):130-7. PubMed ID: 22548845
[TBL] [Abstract][Full Text] [Related]
5. Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation.
Chan J; Maghraby GM; Craig JP; Alany RG
Int J Pharm; 2007 Jan; 328(1):65-71. PubMed ID: 17092668
[TBL] [Abstract][Full Text] [Related]
6. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention.
Alany RG; Rades T; Nicoll J; Tucker IG; Davies NM
J Control Release; 2006 Mar; 111(1-2):145-52. PubMed ID: 16426694
[TBL] [Abstract][Full Text] [Related]
7. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
[TBL] [Abstract][Full Text] [Related]
8. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
9. Phase behavior of the microemulsions and the stability of the chloramphenicol in the microemulsion-based ocular drug delivery system.
Lv FF; Zheng LQ; Tung CH
Int J Pharm; 2005 Sep; 301(1-2):237-46. PubMed ID: 16039810
[TBL] [Abstract][Full Text] [Related]
10. Development of water-in-oil microemulsions with the potential of prolonged release for oral delivery of L-glutathione.
Wen J; Du Y; Li D; Alany R
Pharm Dev Technol; 2013; 18(6):1424-9. PubMed ID: 23742726
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of microemulsions containing orange oil with water and propylene glycol as hydrophilic components.
Yotsawimonwat S; Okonoki S; Krauel K; Sirithunyalug J; Sirithunyalug B; Rades T
Pharmazie; 2006 Nov; 61(11):920-6. PubMed ID: 17152984
[TBL] [Abstract][Full Text] [Related]
13. Formulation of a cosurfactant-free O/W microemulsion using nonionic surfactant mixtures.
Cho YH; Kim S; Bae EK; Mok CK; Park J
J Food Sci; 2008 Apr; 73(3):E115-21. PubMed ID: 18387105
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats.
Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R
Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556
[TBL] [Abstract][Full Text] [Related]
15. Optimized self-microemulsifying drug delivery systems (SMEDDS) for enhanced oral bioavailability of astilbin.
Mezghrani O; Ke X; Bourkaib N; Xu BH
Pharmazie; 2011 Oct; 66(10):754-60. PubMed ID: 22026156
[TBL] [Abstract][Full Text] [Related]
16. A study of the stability of W/O/W multiple emulsions.
Yan N; Zhang M; Ni P
J Microencapsul; 1992; 9(2):143-51. PubMed ID: 1593397
[TBL] [Abstract][Full Text] [Related]
17. High-throughput formulation screening system for self-microemulsifying drug delivery.
Sakai K; Maeda H; Yoshimori T; Obata K; Ogawa Y
Drug Dev Ind Pharm; 2009 Jun; 35(6):746-55. PubMed ID: 19514991
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.
Shen H; Zhong M
J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176
[TBL] [Abstract][Full Text] [Related]
19. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B.
Pestana KC; Formariz TP; Franzini CM; Sarmento VH; Chiavacci LA; Scarpa MV; Egito ES; Oliveira AG
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):253-9. PubMed ID: 18676122
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration.
Borhade VB; Nair HA; Hegde DD
Drug Dev Ind Pharm; 2009 May; 35(5):619-30. PubMed ID: 18979309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
